
Expansion Blitz Masks Margin Squeeze; the Real Test is H2
facility expansion · surgical centers · greenfield ramp

facility expansion · surgical centers · greenfield ramp

greenfield expansion · surgical facility ramp-up · strong SSSG

api manufacturing · margin compression · subsidiary loss

Lannett integration · Margin accretion · US growth

Lannett integration · margin guidance · US growth

acquisition-led growth · cash flow lag · working capital drain

acquisition-led growth · margin expansion · working capital drag

CDMO_growth · Biologics_inflection · Margin_compression

margin compression · unit ramp-up · doubtful debt

unit stabilization · margin compression · insurance empanelment

CDMO · fermentation · MicroBiopharm

bed expansion · margin pressure · ESOP impact

bed expansion · revenue growth · margin pressure

backward integration · ibuprofen pricing · capex execution

backward integration · peptides expansion · ibuprofen volumes

diagnostics · healthcare services · margin expansion

CDMO scaling · export 83% · Viatris partnership

US generics momentum · bosutnib exclusivity cliff · US branded ramp-up

diagnostics · revenue-growth · margin-pressure

19.6% revenue growth · 32.1% EBITDA margin · acquisitions

Noida · EBITDA breakeven · margin expansion

Noida EBITDA breakeven · Cluster 2 growth · capacity expansion

healthcare · ayurveda · hospital expansion

healthcare · margin expansion · capex

CDMO · branded generics · margin expansion

earnings preview · margin expansion · API growth

margin compression · brownfield drag · oncology headwind

margin compression · brownfield ramp-up · oncology headwind

oncology · margin regulation · price caps

revenue growth slowing · PAT decline masked by adjustments · price cap risk